GlassScriptPhysician profile
Payal Shah
NPI 1962406504
$1,875.52
in general payments reported to CMS, 2019-2025
20 companies · $149 in 2025
The $149 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,118 · 2020: $55.28 · 2021: $98.10 · 2022: $103 · 2023: $351 · 2025: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $880.24 | 2019 | |
| Myriad Women'S Health, INC. | $246.58 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $171.23 | 2021-2025 | Acessa Provu System, Novasure, Fluent Fluid Management System |
| Abbvie INC. | $131.36 | 2019-2022 | |
| Bard Access Systems, INC. | $90.97 | 2019 | |
| Astellas Pharma US INC | $61.30 | 2022-2023 | Veozah, Myrbetriq |
| Exact Sciences Corporation | $59.57 | 2023-2025 | Cologuard Collection Kit |
| Celularity INC. | $30.48 | 2019-2020 | |
| Evofem Biosciences, INC. | $30.08 | 2021-2025 | Phexxi, Solosec, Phexx |
| Amgen INC. | $28.69 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.87 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $16.69 | 2023 | Exparel |
| Meditrina | $15.55 | 2023 | |
| Coopersurgical, INC. | $15.00 | 2022 | |
| Duchesnay USA Incorporated | $14.10 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $14.01 | 2019 | |
| Merck Sharp & Dohme LLC | $13.89 | 2019 | |
| Medicem INC. | $13.22 | 2021 | |
| Minerva Surgical, INC | $12.75 | 2019 | |
| Lupin INC. | $11.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Payal Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.